A41.0
Conditions
Interventions
Group 1: Standard of care: no unsolicted infectious disease consultation (15 patients per study center, maximum duration of recruitment 1 year. Then switch of the groups).
Group 2: unsolicited telepho
Sponsors
Center for Sepsis Care and Control
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: documented SAB (staphylococcus aureus bacteremia); written informed consent
Exclusion criteria
Exclusion criteria: Positive blood cultures with other bacteria then S.aureus only; S.aureus infection without bacteremia; patients with limited treatment or end of treatment; patients with a life expectancy <90 days; patients with palliative care
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 30 day mortality | — |
Secondary
| Measure | Time frame |
|---|---|
| adherence to 6 defined quality of care indicators for the treatment of S.aureus bacteremia until hospital discharge. 90-day all-cause mortality 90-day recurrence rate Progression into Sepsis/Septic Shock during 90 days Development of secundary septic foci during 90 days | — |
Countries
Germany
Contacts
Public ContactSebastian Weis
Integriertes Forschungs- und BehandlungszentrumSepsis und Sepsisfolgen (CSCC)Universitätsklinikum Jena
Outcome results
None listed